Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Submitted by
admin
on February 9, 2018 - 9:34am
Source:
Xconomy
News Tags:
Verastem
Infinity Pharma
FDA
duvelisib
CLL
follicular lymphoma
small lymphocytic lymphoma
Headline:
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Do Not Allow Advertisers to Use My Personal information
